ABVC BioPharma (ABVC) up 160% on News

And the Day-Traders Say, I'll Drink to That! LIVE QUOTE

Citius Pharma (CTXR) to Merge Subsidiary, with Publicly Traded SPAC TenX Keane (TENK). Shares...

We Would Define This as Huge News.. Citius Pharma would receive 67.5...

Ardelyx (ARDX) $3.40, Receives FDA Approval.

BooYah, Ardelyx shoots and we score (again) last week..but wait, there's more! It trades down post-approval as short-term...

EyeOnChannel Production Studio & Network

Eye on Channel (EOC) is in its 7th year of operation. EOC is a digital video giant that connects millions of viewers...

Ouch…Omniq (OMQS).

We had fun with this for a good year, doubling after we found it. Adding OmniQ (OMQS) $5.00...

Two Reports and a Profile on Sekur Private Private Data (SWISF).

RELATED: Sekur Private Data Ltd.'s SekurVPN Swiss Hosted, Privacy VPN Records Sales up over 100% Month-Over-Month

SekurMessenger vs. the WhatsApp Messenger.

Can the World’s Most Secure Text Messenger and Email Provider Challenge the Industry Leader WhatsApp? Can A Tiny...

Hapbee’s (HAPB) Revolutionary Sleep Aid, Lands on the Shelves of Target Stores.

When we first came across Hapbee (HAPB) we described it as having a medical technology (a device) that had the "highest potential...

Is Citius Pharma a Ten Bagger?

As is From $0.80 to $8.00.. One of our favorite Broker/Dealer Analysts thinks it is..

Our 10 Top Turnaround Situations Under $5.00.

Can These Stocks Double in Value, and Still be 70% off Their Recent High? Read More...

Latest article

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!